Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.31623 | uM | 8 | 2500.00 | 1955.17 | 4005.00 | 4282.00 | 0.9353 | 0.8852 |
| SK-BR-3 | Erlotinib | 1 | uM | 8 | 2500.00 | 1955.17 | 4096.00 | 4282.00 | 0.9566 | 0.9230 |
| SK-BR-3 | Lapatinib | 10 | uM | 8 | 2500.00 | 1955.17 | 2244.00 | 4282.00 | 0.5241 | 0.1296 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 8 | 2500.00 | 1955.17 | 4583.00 | 4282.00 | 1.0703 | 1.1238 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 8 | 2500.00 | 1955.17 | 4474.00 | 4282.00 | 1.0448 | 1.0791 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 8 | 2500.00 | 1955.17 | 4504.00 | 4282.00 | 1.0518 | 1.0914 |
| SK-BR-3 | Lapatinib | 1 | uM | 8 | 2500.00 | 1955.17 | 2116.00 | 4282.00 | 0.4942 | 0.0724 |
| SK-BR-3 | Linsitinib | 10 | uM | 8 | 2500.00 | 1955.17 | 3499.00 | 4282.00 | 0.8171 | 0.6730 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 8 | 2500.00 | 1955.17 | 4181.00 | 4282.00 | 0.9764 | 0.9582 |
| SK-BR-3 | Erlotinib | 10 | uM | 8 | 2500.00 | 1955.17 | 2621.00 | 4282.00 | 0.6121 | 0.2958 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 8 | 2500.00 | 1955.17 | 4049.00 | 4282.00 | 0.9456 | 0.9035 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 8 | 2500.00 | 1955.17 | 4600.00 | 4282.00 | 1.0743 | 1.1308 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 8 | 2500.00 | 1955.17 | 2905.00 | 4282.00 | 0.6784 | 0.4192 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 8 | 2500.00 | 1955.17 | 2355.00 | 4282.00 | 0.5500 | 0.1788 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 8 | 2500.00 | 1955.17 | 4548.00 | 4282.00 | 1.0621 | 1.1095 |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4489.00 | 4282.00 | 1.0483 | 1.0853 | |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 8 | 2500.00 | 1955.17 | 3996.00 | 4282.00 | 0.9332 | 0.8814 |
| SK-BR-3 | Linsitinib | 1 | uM | 8 | 2500.00 | 1955.17 | 3989.00 | 4282.00 | 0.9316 | 0.8785 |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4147.00 | 4282.00 | 0.9685 | 0.9442 | |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 3942.00 | 4282.00 | 0.9206 | 0.8589 | |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4144.00 | 4282.00 | 0.9678 | 0.9429 | |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4161.00 | 4282.00 | 0.9717 | 0.9500 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 8 | 2500.00 | 1955.17 | 2772.00 | 4282.00 | 0.6474 | 0.3616 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 8 | 2500.00 | 1955.17 | 3641.00 | 4282.00 | 0.8503 | 0.7329 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 8 | 2500.00 | 1955.17 | 4051.00 | 4282.00 | 0.9461 | 0.9043 |